journal
https://read.qxmd.com/read/38389415/sanguinarine-attenuates-lung-cancer-progression-via-oxidative-stress-induced-cell-apoptosis
#21
JOURNAL ARTICLE
Asmat Ullah, Anum Razzaq, Mohammad Y Alfaifi, Serag Eldin I Elbehairi, Farid Menaa, Najeeb Ullah, Somia Shehzadi, Touseef Nawaz, Haroon Iqbal
BACKGROUND: Lung cancer (LC) incidence is rising globally and is reflected as a leading cause of cancer-associated deaths. Lung cancer leads to multistage carcinogenesis with gradually increasing genetic and epigenetic changes. AIMS: Sanguinarine (sang) mediated the anticancer effect in LCC lines by involving the stimulation of reactive oxygen species (ROS), impeding Bcl2, and enhancing Bax and other apoptosis-associated protein Caspase-3, -9, and -PARP, subsequently inhibiting the LC invasion and migration...
2024: Current Molecular Pharmacology
https://read.qxmd.com/read/37982288/maprotiline-prompts-an-antitumour-effect-by-inhibiting-pd-l1-expression-in-mice-with-melanoma
#22
JOURNAL ARTICLE
Lirui Liang, Yang Li, Yang Jiao, Chunjing Zhang, Mingguang Shao, Hanyu Jiang, Zunge Wu, Haoqi Chen, Jiaming Guo, Huijie Jia, Tiesuo Zhao
BACKGROUND: Research has revealed that the expression of PD-L1 is significantly upregulated in tumour cells and that the binding of programmed cell death protein 1 (PD-1) to programmed cell death 1 ligand 1 (PD-L1) inhibits the response of T cells, thereby suppressing tumour immunity. Therefore, blocking PD-L1/PD-1 signalling has become an important target in clinical immunotherapy. Some old drugs, namely, non-anticancer drugs, have also been found to have antitumour effects, and maprotiline is one of them...
2024: Current Molecular Pharmacology
https://read.qxmd.com/read/37982287/targeting-fgfr3-is-a-useful-therapeutic-strategy-for-rheumatoid-arthritis-treatment
#23
JOURNAL ARTICLE
Shan-Fu Yu, Tien-Tsai Cheng, Gong-Kai Huang, Chung-Yuan Hsu, Ying-Hsien Kao, Yueh-Hua Chung
BACKGROUND: Rheumatoid arthritis (RA) is a systemic inflammatory disease in which TNF-α plays an important role. Fibroblast growth factor receptor 3 (FGFR3) is reportedly involved in RA by regulating the expression of inflammatory cytokines. OBJECTIVE: This study examined the expression profile of FGFR3 in human synovial biopsy tissues and evaluated its gene-silencing effects on behaviors of synovial cells. METHODS: Immunohistochemical staining was used to measure FGFR3 expression in human RA joint tissues...
2024: Current Molecular Pharmacology
https://read.qxmd.com/read/37982286/rbm3-accelerates-wound-healing-of-skin-in-diabetes-through-erk1-2-signaling
#24
JOURNAL ARTICLE
Jianguo Feng, Menghong Long, Xin Zhao, Pijun Yan, Yunxiao Lin, Maohua Wang, Wenhua Huang
BACKGROUND: With the increasing risk of infections and other serious complications, the underlying molecular mechanism of wound healing impairment in diabetes deserves attention. Cold shock proteins (CSPs), including CIRP and RBM3 are highly expressed in the skin; however, it is unknown whether CSPs are involved in the wound-healing impairment of diabetic skin. OBJECTIVES: The objective of this study is to investigate the effects of RBM3 on skin wound healing in diabetes...
2024: Current Molecular Pharmacology
https://read.qxmd.com/read/37921143/arsenic-exposure-and-amyloid-precursor-protein-processing-a-focus-on-alzheimer-s-disease
#25
JOURNAL ARTICLE
Ravikant Sharma, M D Abubakar, Priya Bisht, Mahesh Rachamalla, Arun Kumar, Krishna Murti, Velayutham Ravichandiran, Nitesh Kumar
BACKGROUND: Arsenic is present in above permissible safe limits in groundwater, soil, and food, in various areas of the world. This is increasing exposure to humankind and affecting health in various ways. Alternation in cognition is one among them. Epidemiological research has reflected the impact of arsenic exposure on children in the form of diminished cognition. AIMS: Considering this fact, the present study reviewed the impact of arsenic on amyloid precursor protein, which is known to cause one of the commonest cognitive disorders such as Alzheimer's disease...
October 25, 2023: Current Molecular Pharmacology
https://read.qxmd.com/read/37921142/review-of-the-role-of-metabolic-factors-in-determining-the-post-surgical-adhesion-and-its-therapeutic-implications-with-a-focus-on-extracellular-matrix-and-oxidative-stress
#26
JOURNAL ARTICLE
Mahmoud Tavakkoli, Rozita Khodashahi, Mohsen Aliakbarian, Hoda Rahimi, Kiarash Ashrafzadeh, Gordon Ferns, Ebrahim Khaleghi, Mohammad-Hassan Arjmand
The potential role of metabolic reprogramming in fibrogenesis has recently attracted interest. Extracellular matrix stiffness, inflammation, and subsequent oxidative stress are essential mediators in the causation of fibrosis. The prevention of post-surgical adhesion is a challenge in medicine. It is defined as a fibrotic disorder in which adhesive bands develop after abdominal or pelvic surgery. Despite many studies related to the pathogenesis of post-surgical adhesion (PSA), many unknowns exist. Therefore, evaluating different pathways may help characterize and identify the cause of fibrotic scar formation post-operation...
October 25, 2023: Current Molecular Pharmacology
https://read.qxmd.com/read/37916634/all-trans-retinoic-acid-increased-transglutaminase-2-expressions-in-bv-2-cells-and-cultured-astrocytes
#27
JOURNAL ARTICLE
Katsura Takano-Kawabe, Tatsuhiko Izumo, Tomoki Minamihata Minamihata, Mitsuaki Moriyama
BACKGROUND: Activation of microglia and astrocytes has been observed in Alzheimer's disease (AD). Transglutaminase 2 (TG2) is reported to be activated in AD and involved in cell proliferation, differentiation, and inflammation. Moreover, amyloid β (Aβ) aggregation is detected as a characteristic pathology in the AD brain, and is known to be a substrate of TG2. All-trans retinoic acid (ATRA) can modify cell proliferation and differentiation, and is reported to have therapeutic effects on AD pathology...
October 24, 2023: Current Molecular Pharmacology
https://read.qxmd.com/read/37916633/deregulated-micrornas-involved-in-p53-signaling-pathway-in-breast-cancer-with-focus-on-triple-negative-breast-cancer
#28
JOURNAL ARTICLE
Yasaman Naeimzadeh, Zahra Heidari, Vahid Razban, Sahar Khajeh
BACKGROUND: Breast cancer (BC), as a heterogenous disease, is the most common cancer among women worldwide. Triple-negative breast cancer (TNBC) is the most aggressive and malignant subtype with a poor prognosis and a high rate of relapse and metastasis that is closely linked to epithelial-mesenchymal transition (EMT). It is well-documented that miRNAs play oncogenic (oncomiR) or tumor-suppressive (TS-miR) roles in controlling apoptosis (apoptomiR), differentiation, cell proliferation, invasion, migration, etc...
October 24, 2023: Current Molecular Pharmacology
https://read.qxmd.com/read/37904563/regulating-mirnas-expression-by-resveratrol-novel-insights-based-on-molecular-mechanism-and-strategies-for-cancer-therapy
#29
JOURNAL ARTICLE
Atoosa Keshavarzmotamed, Vahide Mousavi, Niloufar Masihipour, Atefe Rahmati, Rohollah Mousavi Dehmordi, Behrooz Ghezelbash, Mina Alimohammadi, Alireza Mafi
Resveratrol, a polyphenolic phytoalexin found in a wide range of plants, including grapes, berries, and peanuts, is an extensively researched phytochemical with unique pharmacological capabilities and amazing potential to affect many targets in various cancers. Resveratrol's anti-cancer activities are due to its targeting of a variety of cellular and molecular mechanisms and crucial processes involved in cancer pathogenesis, such as the promotion of growth arrest, stimulation of apoptosis, suppression of cell proliferation, induction of autophagy, regulating oxidative stress and inflammation, and improving the influence of some of the other chemotherapeutic agents...
October 23, 2023: Current Molecular Pharmacology
https://read.qxmd.com/read/37904562/sglt2-inhibitors-and-diabetic-kidney-disease-targeting-multiple-and-interrelated-signaling-pathways-for-renal-protection
#30
JOURNAL ARTICLE
Georgios Papaetis
Almost 20-40% of all patients suffering from diabetes mellitus experience chronic kidney disease, which is related to higher mortality (cardiovascular and all-cause). The implication of several pathophysiological mechanisms (hemodynamic, tubular, metabolic and inflammatory) in the pathogenesis of diabetic kidney disease generates an urgent need to develop multitarget therapeutic strategies to face its development and progression. SGLT2 inhibitors are undoubtedly a practice-changing drug class for individuals who experience type 2 diabetes and diabetic kidney disease...
October 23, 2023: Current Molecular Pharmacology
https://read.qxmd.com/read/38239068/screening-and-identification-of-esr1-as-a-target-of-icaritin-in-hepatocellular-carcinoma-evidence-from-bibliometrics-and-bioinformatic-analysis
#31
JOURNAL ARTICLE
Yinghui Zhou, Jia Gu, Huiying Yu, Fengyang Chen, Chao Long, Maiweilan Maihemuti, Tingsong Chen, Wei Zhang
BACKGROUND: In 2022, icaritin a Traditional Chinese Medicine with estrogen-like activities was recommended by the CSCO guidelines as a systematic treatment for patients with advanced HCC due to its clinical safety and efficacy. However the mechanism and targets of icaritin are unclear. In this study we aimed to reveal the target of icaritin in HCC. METHODS: First literature related to icaritin was downloaded from the Web of Science. The software programs "Rstudio" "VOSviewer" and "Mendeley Desktop" were used to analyze the distribution of icaritin publications and research hotspots...
October 19, 2023: Current Molecular Pharmacology
https://read.qxmd.com/read/37881074/gentiopicroside-ameliorated-ductular-reaction-and-inflammatory-response-in-ddc-induced-murine-cholangiopathies-model
#32
JOURNAL ARTICLE
Juan Hao, Jian Wu, Quanjun Yang, Kan Lu, Yi Xu, Yiyue Chen, Jibo Liu, Xiaohong Shao, Chunling Zhu, Yaqin Ding, Xin Xie
BACKGROUND: Cholangiopathies comprise a spectrum of diseases without curative treatments. Pharmacological treatments based on bile acid (BA) metabolism regulation represent promising therapeutic strategies for the treatment of cholangiopathies. Gentiopicroside (GPS), derived from the Chinese medicinal herb Gentianae Radix, exerts pharmacological effects on bile acid metabolism regulation and oxidative stress. OBJECTIVE: The present study aims to investigate the effect of GPS on 3,5-diethoxycarbonyl-1,4dihydrocollidine (DDC)-induced cholangiopathy...
October 19, 2023: Current Molecular Pharmacology
https://read.qxmd.com/read/38258596/artemisinin-attenuates-isoproterenol-induced-cardiac-hypertrophy-via-the-erk1-2-and-p38-mapk-signaling-pathways
#33
JOURNAL ARTICLE
Renxing Song, Chunming Xiong, Juncai Bai, Zhenzhou Bai, Wei Liu
BACKGROUND: Artemisinin (ART) is mainly derived from Artemisia annua, a traditional Chinese medicinal plant, and has been found to affect cellular biochemical processes, such as proliferation, angiogenesis, and apoptosis, in addition to its antimalarial properties. However, its effect on cardiac hypertrophy and the underlying mechanisms remain unclear. OBJECTIVES: This study aimed to investigate the effect of ART on cardiac hypertrophy and explore its possible mechanisms...
October 13, 2023: Current Molecular Pharmacology
https://read.qxmd.com/read/38254301/co-treatment-of-astragaloside-iv-with-vitamin-d-in-diabetic-peripheral-neuropathic-rats-protective-effects-and-potential-mechanisms
#34
JOURNAL ARTICLE
Fengyan Tang, Bo Zhao, Li Zhang, Faisal Raza, Hajra Zafar, Shao Zhong, Lin Li, Wenhua Zhu, Lingna Fang, Bing Lu, Liwen Shen, Ping Guo, Nengxing Yu, Quanmin Li
OBJECTIVE: The potential mechanism underlying the protective effect of Astragaloside IV (AS-IV) co-treatment with 1, 25-dihydroxy-vitamin D (Vit-D) on neuropathy in diabetic high-fat rats was investigated. METHODS: The rat diabetic hyperlipidemia (DH) model was established via streptozotocin and a high-fat diet (HFD). After co-treatment (of AS-IV and Vit-D at respective doses of 50 mg/kg via oral gavage and 30000 IU/kg via intramuscular injection), blood glucose levels, markers of inflammation and oxidative stress, as well as apoptosis and histopathology were evaluated with appropriate techniques...
October 13, 2023: Current Molecular Pharmacology
https://read.qxmd.com/read/37936450/dual-role-of-pregnane-x-receptor-in-nonalcoholic-fatty-liver-disease
#35
JOURNAL ARTICLE
Yuan Xu, Ziming An, Shufei Wang, Yiming Ni, Mingmei Zhou, Qin Feng, Xiaojun Gou, Meiling Xu, Ying Qi
The incidence of nonalcoholic fatty liver disease (NAFLD) has been rising worldwide in parallel with diabetes and metabolic syndrome. NAFLD refers to a spectrum of liver abnormalities with a variable course, ranging from nonalcoholic fatty liver (NAFL) to nonalcoholic steatohepatitis (NASH), eventually leading to cirrhosis and hepatocellular carcinoma. Pregnane X receptor (PXR), a member of the nuclear receptor superfamily, plays a prominent part in the regulation of endogenous metabolic genes in NAFLD. Recent studies have suggested that PXR has therapeutic potential for NAFLD, yet the relationship between PXR and NAFLD remains controversial...
October 13, 2023: Current Molecular Pharmacology
https://read.qxmd.com/read/37724681/current-strategies-for-the-management-of-psoriasis-with-potential-pharmacological-pathways-using-herbals-and-immuno-biologicals
#36
JOURNAL ARTICLE
Kiran Singh Sharma, Sumit Kumar
BACKGROUND: Psoriasis is an acute to chronic multifunctional inflammatory skin disorder mediated through T-cell activation, dendritic cell intervention, local vascular variations, atypical keratinocyte proliferation, and neutrophil activation, leading to a skin disorder with no permanent cure. OBJECTIVE: This review aims to find a potent, secure, and dependable medication, with a more scientific examination of herbal resources and recent targeted immunobiological therapies...
September 15, 2023: Current Molecular Pharmacology
https://read.qxmd.com/read/37724680/pf-04449913-inhibits-proliferation-and-metastasis-of-colorectal-cancer-cells-by-down-regulating-mmp9-expression-through-the-erk-p65-pathway
#37
JOURNAL ARTICLE
Yejiao Ruan, Guangrong Lu, Yaojun Yu, Yue Luo, Hao Wu, Yating Shen, Zejun Gao, Yao Shen, Zhenzhai Cai, Liyi Li
INTRODUCTION: Colorectal cancer remains a life-threatening malignancy with increasing morbidity and mortality worldwide. Therefore, new and effective anti-colorectal cancer therapeutics are urgently needed. METHOD: In this study, we have studied the anti-tumor properties and potential mechanisms of PF-04449913. Colorectal cancer cell viability was reduced by PF-04449913 in a dose-dependent manner. The migration and invasion ability of malignant colon cells were attenuated by the drug, as demonstrated by the Transwell test...
September 15, 2023: Current Molecular Pharmacology
https://read.qxmd.com/read/37711005/targeting-mutant-p53-for-cancer-treatment-are-we-there-yet
#38
JOURNAL ARTICLE
Dhi Vya Lim, Wei Hwei Woo, Jing Xuan Lim, Xin Yee Loh, Hui Ting Soh, Seng Yung Adrian Lim, Zheng Yang Lee, Hui Yin Yow, Sharina Binti Hamzah, Sellappans Renukha, Jhi Biau Foo
BACKGROUND: Mutations in the TP53 gene are the most common among genetic alterations in human cancers, resulting in the formation of mutant p53 protein (mutp53). Mutp53 promotes proliferation, migration, invasion, and metastasis in cancer cells. Not only does the initiation of oncogenesis ensue due to mutp53, but resistance towards chemotherapy and radiotherapy in cancer cells also occurs. This review aims to summarise and discuss the oncogenesis of mutant p53 in cancer cells and introduce the various mutant p53 inhibitors currently being evaluated at the pre-clinical and clinical stages...
September 14, 2023: Current Molecular Pharmacology
https://read.qxmd.com/read/37691196/at-the-crossroads-of-tnf%C3%AE-signaling-and-cancer
#39
JOURNAL ARTICLE
Sonal M Manohar
Tumor necrosis factor-alpha (TNFα) is a pleiotropic pro-inflammatory cytokine of the TNF superfamily. It regulates key cellular processes such as death, and proliferation besides its well-known role in immune response through activation of various intracellular signaling pathways (such as MAPK, Akt, NF-κB, etc.) via complex formation by ligand-activated TNFα receptors. TNFα tightly regulates the activity of key signaling proteins via their phosphorylation and/or ubiquitination which culminate in specific cellular responses...
September 8, 2023: Current Molecular Pharmacology
https://read.qxmd.com/read/37691195/a-deeply-quiescent-subset-of-cml-lsc-depend-on-fao-yet-avoid-deleterious-ros-by-suppressing-mitochondrial-complex-i
#40
JOURNAL ARTICLE
Nyam-Osor Chimge, Min-Hsuan Chen, Cu Nguyen, Yuqi Zhao, Xiwei Wu, Paulina Garcia Gonzalez, Heather Ogana, Samantha Hurwitz, Jia-Ling Teo, Xiaolong Chen, Juan Du, Victor Jin, Yong-Mi Kim, Masaya Ono, Rafael J Argüello, Michael Kahn
BACKGROUND AND OBJECTIVE: Disease relapse and therapy resistance remain serious impediments to treating cancer. Leukemia stem cells (LSC) are therapy resistant and the cause of relapse. A state of deep quiescence appears to enable cancer stem cells (CSC) to acquire new somatic mutations essential for disease progression and therapy resistance. Both normal hematopoietic stem cells (HSC) and LSC share many common features, thereby complicating the safe elimination of LSC. A recent study demonstrated that long lived normal oocytes exist without mitochondrial complex I (MC-1), expressing it in a developmentally regulated fashion, thereby mitigating their vulnerability to ROS...
September 6, 2023: Current Molecular Pharmacology
journal
journal
41900
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.